Literature DB >> 20390093

Novel 2-pyrazoline derivatives as potential antibacterial and antifungal agents.

Suvarna Kini1, A M Gandhi.   

Abstract

The 1,3,5-trisubstituted-2-pyrazolines were synthesized by refluxing isoniazid with various substituted diarylchalcones in N,N-dimethylformamide at 120-140 degrees . The physical and spectral data such as M.P., R(f), elemental analysis, IR, NMR and Mass was obtained for the synthesized compounds and the structures were confirmed. The screening of the synthesized compounds for antimicrobial activity was performed against Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, Escherichia coli and Aspergillus niger.

Entities:  

Keywords:  Pyrazolines; antibacterial agents; antifungal agents

Year:  2008        PMID: 20390093      PMCID: PMC2852045          DOI: 10.4103/0250-474X.40344

Source DB:  PubMed          Journal:  Indian J Pharm Sci        ISSN: 0250-474X            Impact factor:   0.975


2-pyrazolines are reported as antibacterial1, antifungal234, antimicrobial5, antiviral6, anti-arthritis7 and antiinflammatory78 agents. Encouraged by these facts, we selected to work on 1,3,5-trisubstituted-2-pyrazolines with different substitutions on the phenyl ring. The antibacterial activity and antifungal activity was screened by cup-plate agar diffusion method and the zone of inhibition for each microorganism at different concentrations of the compounds was measured. Melting points of the compounds were determined on a Toshniwal Scientific melting point apparatus and are uncorrected. Purity of the compounds was checked by Thin Layer Chromatography using precoated Merck Silica gel GF254 micro TLC plates and spots were detected under UV. UV spectra were recorded on UV/Vis spectrophotometer (Shimadzu), UV-1601 PC, IR spectra were recorded in KBr disc on a FTIR_8300, KBr Press (Shimadzu) spectrophotometer at Manipal College Of Pharmaceutical Sciences, Manipal. 1H NMR spectra (DMSO-d6) were obtained using Varian 300 MHz Mercury NMR spectrometer from Shimadzu Analytical Technique Center, Department of Chemistry, Pune University, Pune. Mass spectra of the synthesized compounds were obtained using Mass Spectrometer, Shimadzu QP5050 from Shimadzu Analytical Technique Center, Department of Chemistry, Pune University, Pune. Chemicals were obtained from S.D. Fine Chemicals Ltd dealers from Mangalore. Synthesis of 1,3,5-trisubstituted-2-pyrazolines [compound P13 (5-(4-fluorophenyl)-3-(4-fluorophenyl)-1-isonicotinoyl-pyrazoline)]910 was performed by taking equimolar quantities (0.02 mol) of 4-fluoro benzaldehyde and 4-fluoro acetophenone in a 250 ml conical flask and dissolving in minimum amount of 95% ethanol. The mixture was then cooled and 8 ml of 10% potassium hydroxide solution was added. The mixture was stirred over a magnetic stirrer for a period of 24 h and left in an ice chest overnight. On the next day, the mixture was poured into a beaker containing ice-cold water. Then the aqueous layer was acidified with conc. HCl. The precipitated chalcone (1-(4-fluorophenyl)-3-(4-fluorophenyl)-2-propen-1-one) was filtered at pump and recrystallized from aqueous methanol. IR (KBr)cm−1:1598.9 (C = C), 1660.6 (C = O), 3072.4 (C-H). (1-(4-fluorophenyl)-3-(4-fluorophenyl)-2-propen-1-one) (0.05 mol) was added to isoniazid (0.1 mol) in a 100 ml R.B.F. containing 30 ml of N, N-dimethylformamide. The mixture was refluxed at 120° to 140° for a period of 8-10 h. After cooling, the reaction mixture was poured into a beaker containing ice-cold water and the product separated was scooped off and dried over a clean filter paper. The pyrazoline obtained was recrystallized using benzene-petroleum ether. Single spot on TLC established the purity of the compound. Solvent system used was Hexane: ethyl acetate in 4:1 ratio. IR (KBr)cm−1: 1641.3 (N-C = O), 1595.0 (C = N), 1215.1 (C-N), 2914.2 (C-H,CH2),1H NMR (δ values) ppm: aromatic hydrogens 6.7-8.6 δ (m, 12H,Ar-H), CH2 methylene 3.4 δ (s, 2H, CH2), CH methine 5.6 δ (d, 1H,CH-Ar). The other derivatives were prepared in a similar way with different substituted chalcones according to the scheme of synthesis given in fig. 1. The physical data of the synthesized compounds is given in Table 1.
Fig. 1

Scheme for pyrazoline synthesis.

Where, R1 = -H, -Cl(m), -Cl(p), -F(p), -OCH3(p), -OCH3(m, p), - N(CH3)2(p), -NO2(m) R2 = -F(p), -Cl(p), -Br(p), -OCH3(p).

TABLE 1

PHYSICAL DATA OF THE SYNTHESIZED PYRAZOLINES

PyrazolineR1R2Rf Valuem.p. (°)% Yield
P01-F (p)-Cl (p)0.73132-13351
P02-Cl (m)-Cl (p)0.64123-12555
P03-OCH3 (p)-Cl (p)0.77172-17458
P04-N(CH3)2 (p)-Cl (p)0.11163-16549
P05-Cl (p)-Cl (p)0.1786-8834
P06-OCH3 (m,p)-Cl (p)0.11166-16750
P07-N(CH3)2 (p)-OCH3 (p)0.17188-19052
P08-Cl (p)-OCH3 (p)0.16214-21559
P09-NO2 (m)-OCH3 (p)0.31170-17236
P10-OCH3 (m,p)-OCH3 (p)0.30188-18947
P11-F (p)-Br (p)0.15111-11353
P12-N(CH3)2 (p)-Br (p)0.1496-9832
P13-F (p)-F (p)0.19112-11444
P14-Cl (p)-F (p)0.15162-16365
P15-OCH3 (p)-F (p)0.12157-15858

All the compounds gave satisfactory spectral and elemental data

Scheme for pyrazoline synthesis. Where, R1 = -H, -Cl(m), -Cl(p), -F(p), -OCH3(p), -OCH3(m, p), - N(CH3)2(p), -NO2(m) R2 = -F(p), -Cl(p), -Br(p), -OCH3(p). PHYSICAL DATA OF THE SYNTHESIZED PYRAZOLINES All the compounds gave satisfactory spectral and elemental data All the synthesized compounds were screened in vitro for antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, Escherichia coli at the concentrations 200, 300, 400 and 500 mg/ml and for antifungal activity against Aspergillus niger at 100, 200, 300, 400 μg/ml by cup-plate agar diffusion method11. The concentrations used in screening were chosen after determining the MICs of each compound. The solvent used was dimethylsulfoxide (DMSO) further diluted with water. Muller Hinton agar was used as the growth medium for the bacterial species and Sabouraud's agar was the growth medium for the fungal species. DMSO was used as a control for all the type of microorganisms. The control showed no activity against the strains of microorganisms used. Antimicrobial activity and antifungal activity was measured as a function of diameter of zone of inhibition (mm). The results were compared with standard drugs ciprofloxacin for antibacterial activity and fluconazole for antifungal activity by measuring the zone of inhibition in mm at 200 and 100 μg/ml respectively. At 200 μg/ml, compounds P14 and P15 were found most effective of the synthesized compounds against S. aureus, (zone of inhibition 15 mm) and compound P14 is the most effective among the synthesized compounds at 200 μg/ml against B. subtilis, (zone of inhibition 16 mm). Compounds P02, P08, P09, P10, P11 were the most effective among the synthesized compounds against E. coli, (zone of inhibition 15 mm) and compound P05 was the most effective at 200 μg/ml among the synthesized compounds against P. aeruginosa, (zone of inhibition 21 mm). At 100 μg/ml the maximum diameter of zone of inhibition (20 mm) against Aspergillus niger was observed for compound P08; indicating that, it is the most effective among the synthesized compounds against Aspergillus niger. The results of the antibacterial and antifungal activity are given in Table 2.
TABLE 2

RESULTS OF IN VITRO ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY

CodeS. aureusB. subtilisE. coliP. aeruginosaA. niger





BCDEBCDEBCDEBCDEABCD
P01121315161314161712131416----12131416
P0214161822131415171517192115161820----
P03131415171416171912141617----12131516
P041314151712131516121314161820222614151618
P0512141617--16191314161721242628----
P0612131416121314151213141520222325----
P07---1312131416121314161519222519212324
P08121315161214151715182123----20222426
P0912141618----151617191216202316182022
P1013151720-121416151719211821242615171920
P111213141612131516151721231719222415161819
P1212141517--1214121415171720232516182022
P1312131415121416191213161813151720----
P1415171921161820221416182016182023----
P15151718201415161812131416--------

A, B, C, D, E indicates concentration of compounds at 100 μg/ml, 200 μg/ml, 300 μg/ml, 400 μg/ml and 500 μg/ml, respectively. Ciprofloxacin (200 μg/ml) had 26 mm zone of inhibition for S. aureus, 25 mm for B. subtilis, 26 mm for E. coli, 30 mm for P. aeruginosa microorganisms respectively and fluconazole (100 μg/ml) had 28 mm zone of inhibition for A. niger organism. Figures indicate diameter of the zone of inhibition in mm including the diameter of cup (i.e. 10 mm). ‘-’ indicates resistance.

RESULTS OF IN VITRO ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY A, B, C, D, E indicates concentration of compounds at 100 μg/ml, 200 μg/ml, 300 μg/ml, 400 μg/ml and 500 μg/ml, respectively. Ciprofloxacin (200 μg/ml) had 26 mm zone of inhibition for S. aureus, 25 mm for B. subtilis, 26 mm for E. coli, 30 mm for P. aeruginosa microorganisms respectively and fluconazole (100 μg/ml) had 28 mm zone of inhibition for A. niger organism. Figures indicate diameter of the zone of inhibition in mm including the diameter of cup (i.e. 10 mm). ‘-’ indicates resistance.
  1 in total

1.  Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents.

Authors:  R A Nugent; M Murphy; S T Schlachter; C J Dunn; R J Smith; N D Staite; L A Galinet; S K Shields; D G Aspar; K A Richard
Journal:  J Med Chem       Date:  1993-01-08       Impact factor: 7.446

  1 in total
  2 in total

1.  TfOH mediated intermolecular electrocyclization for the synthesis of pyrazolines and its application in alkaloid synthesis.

Authors:  Sesuraj Babiola Annes; Pothiappan Vairaprakash; Subburethinam Ramesh
Journal:  RSC Adv       Date:  2018-08-24       Impact factor: 4.036

2.  Eco-friendly synthesis and antimicrobial activities of some 1-phenyl-3(5-bromothiophen-2-yl)-5-(substituted phenyl)-2-pyrazolines.

Authors:  Ramalingam Sasikala; Kannan Thirumurthy; Perumal Mayavel; Ganesamoorthy Thirunarayanan
Journal:  Org Med Chem Lett       Date:  2012-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.